iN1011-N17
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for iN1011-N17, covering 2024-06-21 to 2024-06-24. Get the full timeline:
Most recent: Clinical Trial Update: A MAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers and PHN Patients. [Phase 1]